| Trial ID: | L0562 |
| Source ID: | NCT02133534
|
| Associated Drug: |
Atorvastatin
|
| Title: |
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02133534/results
|
| Conditions: |
Chronic Kidney Disease|High Cholesterol
|
| Interventions: |
DRUG: Atorvastatin
|
| Outcome Measures: |
Primary: Improved Counts of Endothelial Progenitor Cells, Improvement of endothelial cell (EC) dysfunction will be assessed by improved counts of endothelial progenitor cells., baseline, 30 days |
|
| Sponsor/Collaborators: |
Sponsor: Duke University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
1
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-02
|
| Completion Date: |
2009-05
|
| Results First Posted: |
2014-07-03
|
| Last Update Posted: |
2014-07-03
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02133534
|
